Lockheed Martin (LMT) Q2 Earnings Top Estimates

Lockheed Martin (LMT) reported Q2 earnings of $7.29 per share, significantly surpassing the Zacks Consensus Estimate of $6.49, marking its fourth consecutive EPS beat. However, the company's quarterly revenues of $18.16 billion missed consensus by 2.21%. Despite the strong earnings surprise, LMT shares have underperformed the S&P 500 year-to-date, and the stock currently carries a Zacks Rank #4 (Sell) due to unfavorable estimate revisions, suggesting potential near-term underperformance within the Aerospace-Defense industry, which is also ranked in the bottom 37%.

Analysis

Lockheed Martin's (LMT) Q2 2025 results present a conflicting narrative for investors. The company delivered a significant bottom-line beat, with adjusted EPS of $7.29 surpassing the Zacks Consensus Estimate of $6.49 by 12.33%, marking its fourth consecutive quarter of positive earnings surprises. However, this profitability was not matched on the top line, as revenues of $18.16 billion missed consensus by 2.21%. This represents the third revenue miss in the last four quarters, indicating a persistent challenge in achieving sales growth despite a slight year-over-year increase from $18.12 billion. The market appears to be pricing in this top-line weakness, with the stock having lost 5.2% year-to-date, starkly underperforming the S&P 500's 7.2% gain. Compounding the concerns are unfavorable forward-looking indicators; LMT holds a Zacks Rank #4 (Sell) due to negative earnings estimate revisions heading into the report, and its Aerospace - Defense industry is poorly positioned in the bottom 37% of Zacks-ranked industries.

Key Decisions for Investors

• Investors should weigh Lockheed's demonstrated ability to consistently beat EPS estimates against the recurring revenue shortfalls, which suggest potential margin pressure or forecasting challenges.
• Given the stock's significant year-to-date underperformance and its current Zacks Rank #4 (Sell), initiating or adding to long positions carries elevated near-term risk without a positive catalyst.
• The forthcoming management commentary on the earnings call is a critical data point; focus on explanations for the revenue miss and any revisions to forward guidance, as this will likely dictate the stock's immediate trajectory.